Research Topic · Peer-Reviewed

Bioequivalence Cardiovascular Products

Bioequivalence of cardiovascular products refers to demonstrating that two formulations of a medicine used to treat heart and circulatory conditions, such as a generic version and its reference product, deliver the active ingredient to the body at a comparable rate and to a comparable extent. When bioequivalence is …

Curated from this journal's research 📚 1 peer-reviewed article cited Cited 7× across the literature 🔖 ISSN 2328-0182 🗓 Reviewed July 2026

Overview

Bioequivalence of cardiovascular products refers to demonstrating that two formulations of a medicine used to treat heart and circulatory conditions, such as a generic version and its reference product, deliver the active ingredient to the body at a comparable rate and to a comparable extent. When bioequivalence is established, the products are expected to produce similar therapeutic effects and safety, allowing one to be used in place of the other. This is especially important for cardiovascular drugs, many of which are taken long term to manage conditions such as high blood pressure, abnormal heart rhythms, or cholesterol, where consistent and predictable exposure is essential. Bioequivalence is assessed mainly through pharmacokinetic studies comparing blood concentration profiles over time, supported by validated analytical methods that measure the drug precisely in biological samples. Within the journal's coverage of Advanced Pharmaceutical Science And Technology, bioequivalence assessment links bioanalytical chemistry, pharmacokinetics, and the development and regulation of generic medicines. This page gathers peer-reviewed, open-access research relevant to bioequivalence studies in the context of cardiovascular products, supporting readers interested in formulation comparison, pharmacokinetic evaluation, and the scientific basis for ensuring that cardiovascular medicines perform reliably and equivalently.

Research published in this journal

1 peer-reviewed article, ranked by relevance. Each links to its DOI.

How this research is being cited

The 1 article above has been cited 7 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Bioequivalence Cardiovascular Products, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Advanced Pharmaceutical Science And Technology (ISSN 2328-0182).

Journal editorial board
natalia malara · Italy Saba Khalilpour · Italy Haseeb Khan · United States

This page summarises published research for orientation; it is not medical or professional advice.